Resultados de la búsqueda 81-90 of 16817 for lisinopril

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...

3. Cirugía - Ensayos clínicos - Mayo Clinic

   Patients undergoing spine lumbar surgery will be asked to perform short exams/questionnaires aimed at determining cognitive function, quality of life, health ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Drugs used in chemotherapy, such as carboplatin, cisplatin, and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells ...

6. Cirugía - Ensayos clínicos - Mayo Clinic

   This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...